Squamous Cell Non-small Cell Lung Cancer Completed Phase 3 Trials for Carboplatin (DB00958)

Also known as: Squamous Cell Carcinoma, Non-Small-Cell Lung / Lung Non-Small Cell Squamous Carcinoma / Non-Small Cell Squamous Lung Carcinoma / Non-Small Cell Squamous Lung Cancer / Squamous Non-Small Cell Lung Cancer (sqNSCLC) / Squamous NSCLC / Squamous Non-Small Cell Lung Cancer / Squamous cell cancer Non-small cell lung cancer / Squamous non-small cell lung cancer (disorder) / Epidermoid carcinoma lung / Squamous cell carcinoma of lung stage unspecified / Lung squamous cell carcinoma stage unspecified / Squamous cell carcinoma of lung (disorder) / Squamous cell carcinoma of lung

IndicationStatusPhase
DBCOND0059210 (Squamous Cell Non-small Cell Lung Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02027428Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerTreatment
NCT03629925Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLCTreatment
NCT02106546Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerTreatment
NCT02367794A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]Treatment
NCT01285609Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and CarboplatinTreatment